Equity Analysis /
United States of America

US : Aerie Pharmaceuticals, Inc. - AERI | Weekly Rx Metrics: Modest Downtick in Glaucoma Franchise, Remains In-Line With Broader Trends

    Michael Parolari
    Michael Parolari

    Research Associate

    CGS-CIMB
    25 March 2022
    Published by